Organizing Committee
Biography
Denis Viktorovich Butnaru was born on the 28th of June in 1978 in Bălți, Moldovian SSR. 1994 – 1996 – studied in Bălți medical college. 1996 – 2002 – studied General Medicine in Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova. 2002 – 2004 – residentship at the Department of Urology of the I. M. Sechenov Moscow State Medical Academy. 2004 г. – 2008 г. – PhD studies at the Department of Urology of the I. M. Sechenov Moscow State Medical Academy. 2008 г. – PhD thesis defense (The effects of vitamins, antioxidants, and phytoestrogens on risk of the development of prostate cancer). Since 2010, D. V. Butnaru has been actively working on the issues of reconstructive urogenital surgery (ureteral strictures, in particular). 2011 – traineeship at The Center for Reconstructive Urethral Surgery in Arezzo, Italy, under supervision of its Head, Professor Guido Barbagli. 2011 – 2012 – Head of the Surgical Department at the Urological Clinic of the I. M. Sechenov First Moscow State Medical University. 2012 – 2015 – In 2012, D. V. Butnaru became the Head of the Department of Reconstructive-Plastic Uronephrology at the Uronephrology Research Institute of the I. M. Sechenov First Moscow State Medical University. 2012 г. – second traineeship at The Center for Reconstructive Urethral Surgery in Arezzo, Italy, under supervision of its Head, Professor Guido Barbagli. 2013 г. – traineeship at the Wake Forest Institute for Regenerative Medicine, NC, USA, under supervision of its Director, Professor Anthony Atala. 2013 г. – D. V. Butnaru conducted the first tissue-engineered urethral substitution in patient with bulbar urethral stricture. 2014 г. – traineeship at the Center for Reconstructive Urogenital Surgery, Belgrad, Serbia under supervision of its Director, Professor Rados Djinovic. Since 2015 D. V. Butnaru is an Associate Professor of the Department of Urology at the I. M. Sechenov First Moscow State Medical University. In June 2015 D. V. Butnaru was appointed as the Deputy Director of Research of the Uronephrology Research Institute. Since the 1st of Sep-tember in 2016 D. V. Butnaru works as the Director of the Institute for Regenerative Medicine (IRM). 2016 – second traineeship at the Wake Forest Institute for Regenerative Medicine, NC, USA, under supervision of its Director, Professor Anthony Atala. 2016 г. – official visit to the University of Cambridge, the United Kingdom, for the purpose of establishing ties with leading specialists in regenerative medicine and tissue engineering and studying more about the organization of research and education at one of the world’s top univer-sities.
Research Interest
Regenerative Medicine, tissue engineering, Urology
Biography
Nelson R. Pinto: University of the Andes, Faculty of Dentistry, Santiago, CHILE. Visiting Professor, Department of Oral HealthSciences / Periodontology , University Hospitals, Catholic University Leuven, BELGIUM. Founder and Chairman of the Research Center of Regenerative Medicine and Tissue Engineering, Concepción, CHILE. Clinical Editor POSEIDO JOURNAL. World Leader on Clinical Applications of L-PRF in Hard and Soft Tissue Regeneration and Wound Healing. Developer of the Technique for the Treatment of Chronic Wounds with L-PRF. (Best Oral Research Presentation: 4th Congress of the World Union of Wound Healing Societies, Yokohama, Japan, 2012) National and International Lecturer on Implant Dentistry and Regenerative Medicine.
Research Interest
Regenerative Medicine, Tissue Regeneration, Wound Healing, Implant Dentistry
Biography
Dr. Jyh-Ping Chen has been a professor in Chemical and Materials Engineering at Chang Gung University since 1997. He received his BS degree in Chemical Engineering from National Taiwan University in 1981 and PhD in Chemical Engineering from Pennsylvania State University in 1988. He worked for United Biomedical Inc. and University of Wisconsin-Madison in the US before returning to Taiwan and joined the Department of Chemical Engineering of National Cheng Kung University as an associate professor in 1991. He moved to Chang Gung University in 1994 and established the Graduate Institute of Biochemical and Biomedical Engineering in 2002 and served as the first director of the institute till 2006. He was the head of the Chemical and Materials Engineering Department from 2006 to 2014. Professor Chenhas published more than 110 papers in peer-reviewed journals with more than 2100 citations. He is a guest editor or editorial board member for eleven international journals and a peer reviewer for more than 40 reputed journals.His current research interests include biomaterial, bionanotechnology and tissue engineering.
Research Interest
Biomaterials , Tissue Engineering, Nanomedicine, Drug and Gene Delivery ,Biomedical Nanotechnology, Biochemical Engineering
Biography
Alain Chapel, PhD, scientific investigator at the Institute of Radioprotection and Nuclear Safety (IRSN), in the Laboratory of Radiopathology and Experimental Therapies. For 25 years, he has been developing gene and cell therapy using non-human primates and immune-tolerant mice and rats to protect against the side effects of radiation. He has developed representative experimental models of SAI to investigate the effect of radiation on both radiosensitive hematopoietic cells and their bone marrow microenvironment. He collaborates with clinicians to develop new strategies for treatment of patients after radiation accidents or radiotherapy overexposures. In compassional trials, he has participated in the first establishment of proof of concept of the therapeutic efficacy of Mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. In collaboration with Saint-Antoine Hospital (Paris, France), he has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. Currently his work focuses on the development of radio-induced bone marrow aplasia using human hematopoietic stem cells derived from human IPS and the development of new clinical trial of phase2. He is a member of various learned national and international societies: European Bone Marrow Transplantation Group (EBMT), American Society for Hematology, International Society of Stem Cell Research, Société Francaise de Greffe moelle et de thérapie cellulaire. He is an associate editor of height international journals: World Journal of Stem Cells, World Journal of Gastrointestinal Surgery, World Journal of Radiology, World Research Journal of Gene Therapy, The Open Gene Therapy Journal, Research Journal of Developmental Biology, Journal of Toxicology and Health and Journal of Clinical Rehabilitative Tissue Engineering Research, Science Reports. He has participated in the scientific organization of international conferences: European Group for Blood and Marrow Transplantation (EBMT Paris 2011) and World Biotechnology Congress (Boston, USA, 2013-2016).Hirsch index 24.
Research Interest
Radiobiology, Stem Cell therapy
Biography
Dr. Zeng is exploring one of the most hopeful prospects of current biomedical research – that versatile stem cells may some day be a source of replacement cells for damaged tissues of the brain and other organs. She is working toward a treatment for Parkinson’s disease, which causes the death of nerve cells in the brain that are needed for agile and controlled muscle movement. Symptoms of the disabling malady include hand tremors and an inability to walk. Dr. Zeng has developed methods to induce stem cells to transform into the type of nerve cells that are depleted in Parkinson’s disease. These nerve cells produce dopamine, a chemical signal that helps deliver the brain’s orders to the muscles. Her team has been able to derive such nerve cells from embryonic stem cells, and also from the modified adult cells called induced pluripotent stem cells. These induced pluripotent stem cells can mimic the versatility of embryonic stem cells. The Zeng lab has tailored a process to make and purify its nerve cell preparations to improve their safety as potential treatments in humans. These nerve cells could also be used for the testing of potential new drugs, and for basic research on the mechanisms of disease. Dr. Zeng earned a PhD in Molecular Biology at the Technical University of Denmark, and then began research on human embryonic stem cells during her postdoctoral training at the National Institutes of Health. She joined the Buck Institute in 2005. The California Institute for Regenerative Medicine, the state’s stem cell research funding agency, has awarded Zeng grant funds to establish a shared research laboratory and to develop a stem cell course as well as to lead an effort to get a stem cell treatment for Parkinson’s disease ready for clinical trials.
Research Interest
Stem cell treatments for Parkinson's disease, embryonic and human pluripotent stem cells, stem cell technology
Biography
Dr. Fenniri was educated at the University of Louis Pasteur in Strasbourg, France, receiving his undergraduate degree in chemistry and biochemistry (1989, top of his class), and his M.Sc./Ph.D. degrees in supramolecular science and engineering (1990/1994) under the supervision of Professor Jean-Marie Lehn (Nobel Laureate). He then joined the Scripps Research Institute in California, USA, where he carried out his postdoctoral training under the supervision of Professor Richard A. Lerner (President and CEO). In 1997 he moved to Purdue University, where he initiated his independent academic career, and established the Purdue Laboratory for Chemical Nanotechnology (1999). In 2003, He joined the National Research Council and the University of Alberta to build and lead the Supramolecular Nanoscale Assembly program, and contribute to the shaping of the National Institute for Nanotechnology (NINT), its research programs and facilities, and the recruitment of highly qualified personnel. NINT has since grown from 4 principal investigators in 2003 to a vibrant research and technology organization of over 350 researchers in 2013. In addition, Dr. Fenniri held a full professor position with the Department of Chemistry (since 2003-2013) and adjunct full professor positions with the department of biomedical engineering (since 2010) with the faculty of medicine, and with the department if Chemistry (since 2013) at the University of Alberta. Dr. Fenniri is currently Professor Chemical and Biomedical Engineering at Northeastern University, Boston, MA, USA. Dr. Fenniri has achieved international recognition as a leader in the areas of self-assembly, supramolecular chemistry, nanomedicine, combinatorial chemistry, and materials sciences. His group works at the forefront of basic and applied nanosciences, in collaboration with various academic institutions, federal laboratories, and with the private sector. Dr. Fenniri’s contributions appeared in over 190 publications, 8 patents, and over 400 contributed national and international conference papers. Dr. Fenniri has also presented his work in over 150 invited distinguished lectures, colloquia and seminars around the globe. His research programs are supported by the Natural Science and Engineering Research Council of Canada, Alberta Advanced Education and Technology, the US National Institutes of Health, the National Research Council of Canada, the University of Alberta, and several private, provincial and federal funding organizations. Dr. Fenniri is the recipient of several academic and professional honours and awards, including the Xerox UAC Award (2006–2008), the 3M Faculty Award (2000, 2002), the Showalter Trust Fund Award (1999, 2001), the Trask Trust Fund Technology Innovation Award (2000), the Cottrell Teacher Scholar Award (2000–2005), and the US National Science Foundation Career Award (1999–2003). Dr. Fenniri is Member of the Editorial Board of several scientific journals and serves on several national and international scientific boards, panels, and committees. Dr. Fenniri has been an invited professor at the Université de Strasbourg and the Collège de France (2010), the National University of Taiwan (2007), and the University of Colorado Boulder, USA (2004). He has also been DAAD Visiting Professor at Regensburg University, Germany (2002, 2003).
Research Interest
Nanotechnology for biomedical applications, nanoscale materials for drug delivery, and cell therapeutics and regenerative medicine.
Biography
Giacomo Cao is currently working as a Professor of Chemical Engineering, is currently the Coordinator of the Ph.D. Program in Biomedical Engineering at the University of Cagliari, Italy and the Head of the Bioengineering Group at CRS4, Italy. The main research interests in the field of biomedical engineering are the design of rotating bioreactors for engineered cartilage growth, the experimental analysis and modeling of in vitro proliferation of mesenchymal stem cells, the use of human mesenchymal stem cells for acute toxicity tests as well as the development of novel processes for tissues decellularization and recellularization.
Research Interest
Bioengineering, mesenchymal stem cells, tissues decellularization, recellularization
Biography
Roberta Di Pietro got the degree in Medicine cum Laude in 1985 and the PhD in Sports Medicine cum Laude in 1988, University of Chieti, Italy. She worked as a visiting scientist in UK at the Biochemistry Department, AFRC, Cambridge; in USA at the Pathology Department, USUHS, Bethesda, and at the Institute of Human Virology, University of Maryland, Baltimore. She currently works at the G. d’Annunzio University of Chieti, Italy, as a Full Professor of Histology. She joined the Editorial Board of Current Pharmaceutical Design as an Executive Guest Editor and since 2010 she was recognized as a Registered Referee for Archives of Ophthalmological Reviews and Reproductive Biology and Endocrinology. She is now author of 168 scientific publications plus international e-bookchapters and Italian textbooks.
Research Interest
Histology, Embryology, Aging Science
Biography
Assoc. Prof. Julien Freitag's practice is focused on the active management of musculoskeletal conditions including osteoarthritis. He is an authority in the area of clinical regenerative musuloskeletal medicine and has published numerous articles, including those in peer reviewed international journals. He is the Principle Clinical Investigator in a number of world leading research projects assessing the benefits of stem cell therapy in arthritis. His work in the field of clinical translational development was recognized by Charles Sturt University with his appointment as an Adjunct Associate Professor. He is a member of the International Cartilage Repair Society and the Australasian Society of Stem Cell Research.
Research Interest
sports medicine, stem cell research
Biography
Murugan Ramalingam is an Associate Professor of Biomaterials and Tissue Engineering at the Faculty of Dental Surgery, University of Strasbourg (UdS), France. Concurrently he holds an Adjunct Associate Professorship at the Tohoku University (Japan). Prior to joining the UdS, he worked as an Assistant Professor at the WPI-Advanced Institute for Materials Research, Japan. He has also worked at the National Institute of Standards and Technology (NIST, USA) and National Institutes of Health (NIH, USA) under the U.S. National Academies Associateship program. He received his Ph.D. (Biomaterials) from the University of Madras. He has also undergone training in "Ethical and Policy issues on Stem Cells" from the Harvard University, and in "Operations Management" from the University of Illinois-Chicago. His current research interests are focused on the development of multiphase biomaterials, through conventional to nanotechnology to biomimetic approaches, cell patterning, stem cell differentiation and tissue engineering.He has authored over 140 publications including peer-reviewed journal papers, conference proceedings, book chapters, authored/edited books, and patents relevant to biomaterials and tissue engineering, with h-index of 17. He is a co-author of “Biomaterials: A Nano Approach†(CRC Press), and co-editor of “Integrated Biomaterials in Tissue Engineering†(Wiley-Scrivener Publication) and “Biomaterials and Stem Cells in Regenerative Medicine†(CRC Press). He serves on the editorial boards of multiple biomaterials and tissue engineering related journals, including Editor-in-Chief of Journal of Biomaterials and Tissue Engineering and Journal of Bionanoscience. He is also a recipient of CSIR fellowship (India), SMF fellowship (Singapore), NRC Fellowship (USA), National Professorship (France) and Fellow of Royal Society of Chemistry (UK). Further details can be obtained from his homepage at http://www.biomaterialsgroup.page4.me/
Research Interest
Biomaterials,Tissue engineering, Stem Cell, Nanotechnology to Biomimetic approaches, Cell Patterning, Drug Delivery